Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Ultragenyx Pharmaceutical Inc.    RARE

ULTRAGENYX PHARMACEUTICAL INC.

(RARE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Upcoming events on ULTRAGENYX PHARMACEUTICAL INC.
02/23/21 FY 2020 Earnings Release (Projected)
05/10/21 Q1 2021 Earnings Release (Projected)
08/05/21 Interim 2021 Earnings Release (Projected)
11/08/21 Q3 2021 Earnings Release (Projected)
Past events on ULTRAGENYX PHARMACEUTICAL INC.
12/02/20 | 01:00pm Evercore ISI HealthCONx Conference
12/01/20 Piper Sandler Health Care Conference
11/16/20 | 03:00pm Barclay Gene Editing & Gene Therapy Summit
11/10/20 | 02:00pm Credit Suisse Healthcare Conference
Upcoming sector events for ULTRAGENYX PHARMACEUTICAL INC.
12/04/20 | 12:00pm MODERNA, INC. : Nasdaq Virtual Investor Conference
12/05/20 ACCELERON PHARMA INC. : American Society of Hematology Meeting - Thalassemia and Globin Gene Regulation
12/05/20 | 10:00am BLUEPRINT MEDICINES CORPORATION : American Society of Hematology Meeting - Abstract No 1248
12/05/20 | 10:00am BLUEPRINT MEDICINES CORPORATION : American Society of Hematology Meeting - Abstract No 1638
More events
Past sector events for ULTRAGENYX PHARMACEUTICAL INC.
12/03/20 | 02:15pm NOVAVAX, INC. : Evercore ISI HealthCONx Conference
12/03/20 | 11:20am KODIAK SCIENCES INC. : Evercore ISI HealthCONx Conference
12/03/20 | 10:45am ASCENDIS PHARMA A/S : Evercore ISI HealthCONx Virtual Conference
12/03/20 IONIS PHARMACEUTICALS, INC. : Piper Sandler Health Care Conference
Annual publications
Annual results201520162017201820192020 (e)
Sales
M $
Released
Forecast
Spread


0,13
0,15
-8,8%
2,61
0,53
390%
51,5
48,4
6,3%
104
103
1,0%

247
Operating income
(EBITDA)
M $
Released
Forecast
Spread
-136
-133
-2,8%
-245
-239
-2,4%
-323
-322
-0,30%
-352
-366
3,9%
-416
-421
1,2%

-289
Operating profit
(EBIT)
M $
Released
Forecast
Spread
-138
-135
-1,7%
-248
-245
-1,1%
-329
-319
-3,0%
-371
-376
1,2%
-424
-429
1,1%

-304
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
-146
-135
-8,2%
-246
-242
-1,6%
-318
-309
-3,1%
-197
-202
2,2%
-399
-382
-4,5%

-239
Net income
M $
Released
Forecast
Spread
-146
-135
-8,2%
-246
-242
-1,6%
-302
-310
2,5%
-198
-202
2,1%
-403
-385
-4,5%

-240
EPS
$
Released
Forecast
Spread
-3,96
-3,63
-9,1%
-6,21
-6,14
-1,1%
-7,12
-7,30
2,4%
-3,97
-4,03
1,4%
-7,12
-6,84
-4,0%

-3,87
Announcement Date02/25/201602/16/201702/20/201802/19/201902/13/2020

Quarterly publications
Previous periodNext period
Quarterly results2019 Q32019 Q42020 Q12020 Q22020 Q32020 Q4 (e)
Sales
M $
Released
Forecast
Spread
25,8
29,1
-11%
35,6
34,5
3,1%
36,3
36,7
-1,2%
61,7
39,5
56%
81,5
55,8
46%

67,2
Operating income
(EBITDA)
M $
Released
Forecast
Spread


-92,3
-89,0
-3,7%


-59,9




-65,0
Operating profit
(EBIT)
M $
Released
Forecast
Spread
-118
-101
-17%
-94,5
-99,2
4,8%
-121
-93,8
-29%
-63,1
-94,6
33%
-50,3
-76,6
34%

-70,0
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
-113
-99,7
-13%
-91,2
-95,9
4,9%
-119
-93,2
-27%
25,7
-94,7
127%
-68,5
-75,9
9,7%

-72,3
Net income
M $
Released
Forecast
Spread
-113
-99,1
-14%
-93,8
-71,8
-31%
-119
-92,8
-28%
25,3
-92,2
127%
-68,8
-78,5
12%

-70,6
EPS
$
Released
Forecast
Spread
-1,96
-1,68
-17%
-1,62
-1,36
-19%
-2,05
-1,68
-22%
0,41
-1,53
127%
-1,13
-1,28
12%

-1,12
Announcement Date11/05/201902/13/202005/06/202007/30/202010/27/2020

Financial data source
© 2020 S&P Global Market Intelligence
© 2020 Factset
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise